IntrinsicIntrinsic
← Scroll for more →

Financial Statements — DNTH

Balance Sheet

(in billions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents0.060.110.630.050.060.010.010.020.030.310.330.130.160.060.050.020.060.050.070.01
Short-term Investments0.780.780.480.350.350.240.250.250.250.050.050.040.03----0.050.070.080.080.05
Accounts Receivable0.000.000.000.000.010.000.000.000.000.000.000.000.00----0.00------0.00
Total Current Assets0.860.901.120.410.410.260.270.280.290.370.380.180.190.080.080.120.130.140.160.18
Property, Plant & Equipment0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.010.010.010.00
Total Non-current Assets*0.420.320.130.120.160.060.080.090.070.000.000.000.000.000.00(0.03)0.030.030.03(0.17)
Total Assets1.281.211.250.530.580.330.350.370.350.370.380.180.190.080.080.080.160.180.190.01
Accounts Payable0.010.010.010.010.010.010.010.000.010.000.000.000.000.000.000.000.000.000.000.00
Total Current Liabilities0.030.030.040.030.020.020.020.020.020.010.010.010.010.000.010.010.010.010.010.01
Total Non-current Liabilities*0.010.010.010.010.010.000.000.000.000.000.000.000.000.000.00(0.01)0.030.030.03(0.01)
Total Liabilities0.030.040.050.040.030.020.020.020.020.010.010.010.010.000.010.010.040.040.040.01
Retained Earnings(0.47)(0.43)(0.38)(0.34)(0.27)(0.24)(0.20)(0.17)(0.15)(0.12)(0.10)(0.09)(0.08)(0.43)(0.43)(0.40)(0.38)(0.37)(0.35)(0.33)
Total Stockholder Equity1.241.171.200.490.550.300.330.350.340.360.370.170.180.070.080.110.120.140.15(0.02)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Total Revenue------0.280.400.191.161.33--------0.92------1.17------
Research & Development45.6048.6934.5359.9032.4926.2527.0026.4125.5418.0713.0816.757.960.148.0015.7911.2011.6016.5513.11
Selling, General & Admin14.0813.5612.479.938.208.877.346.836.536.005.64(2.01)8.725.326.135.946.056.487.297.03
Total Operating Expenses59.6862.2447.0069.8340.6835.1234.3433.2432.0724.0718.72(5.19)16.687.3832.1321.7317.2518.0823.8320.14
Operating Income(58.47)(61.48)(46.53)(69.54)(40.29)(34.93)(33.18)(31.92)(29.90)(22.20)(17.84)7.09(15.76)(7.37)(32.13)(21.73)(17.25)(18.08)(23.83)(20.14)
Net Income(46.64)(50.21)(40.83)(64.43)(36.76)(31.63)(29.51)(28.44)(25.17)(17.61)(13.75)3.66(14.76)(3.28)(29.17)(20.18)(16.06)(17.27)(22.95)(19.29)
Basic EPS(0.81)(0.90)(0.85)(1.53)(0.97)(0.88)(0.82)(0.76)(0.74)(0.51)(0.54)(4.14)(3.78)(0.05)(0.48)(0.34)(0.27)(0.29)(0.39)(0.31)
Diluted EPS(0.81)(0.90)(0.85)(1.53)(0.97)(0.88)(0.82)(0.76)(0.74)(0.51)(0.54)(4.14)(3.78)(0.05)(0.48)(0.34)(0.27)(0.29)(0.39)(0.31)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow(50.33)(48.98)(28.86)(46.98)(30.55)(23.89)(27.63)(27.44)(21.27)(14.53)(14.94)(11.85)17.14(6.54)(35.60)(16.69)(13.81)(16.85)(19.74)(15.69)
Capital Expenditures0.370.180.010.140.010.050.020.030.030.020.030.010.100.000.250.000.160.130.030.02
Free Cash Flow*(50.70)(49.16)(28.87)(47.12)(30.56)(23.94)(27.65)(27.47)(21.29)(14.54)(14.97)(11.86)17.04(6.54)(35.84)(16.69)(13.97)(16.98)(19.77)(15.70)
Investing Cash Flow(111.87)(478.52)(133.97)37.20(201.27)26.4514.79(23.11)(259.36)1.17(5.51)(8.24)(16.88)18.8726.5015.2215.24(0.13)(40.14)(10.32)
Financing Cash Flow107.4710.38739.414.88274.510.570.1639.680.30(2.20)217.85(4.86)138.440.000.000.072.760.05--0.12
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Dividends Per Share0.000.000.000.000.000.000.000.000.000.000.000.000.00
← Scroll for more columns →